Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM149PT
TNBC
Basal B
17-AAG
HSP90
HSP90
7917.05
uM
0.07638
0.10187
-0.8935 -0.5108 2.4441 0.7937
0.9560
2.7707
SUM149PT
TNBC
Basal B
17-AAG
HSP90
HSP90
9830.037
uM
0.09982
0.11760
-0.7885 -0.6346 5.0000 0.8785
0.9922
1.9735
SUM149PT
TNBC
Basal B
5-DFUR
TYMS
TYMS
10819.143
uM
151.47010
486.00090
-0.1480 -0.4468 0.5477 0.3192
0.9850
2.2570
SUM149PT
TNBC
Basal B
5-DFUR
TYMS
TYMS
11937.143
uM
106.82530
436.03180
-0.2445 -0.5597 0.5340 0.3543
0.9875
2.3169
SUM149PT
TNBC
Basal B
5-FU
TYMS
TYMS
9830.017
uM
97.75580
883.00870
-0.6719 -0.9999 0.4991 0.5226
0.9934
1.8576
SUM149PT
TNBC
Basal B
5-FU
TYMS
TYMS
7917.13
uM
178.68030
1000.00000
-0.5424 -0.8116 0.5600 0.4480
0.9950
2.7649
SUM149PT
TNBC
Basal B
Afatinib
EGFR/HER2
ErbB
11937.158
uM
0.19185
1.70740
-0.8261 -1.0000 0.5026 0.6361
0.9481
2.2386
SUM149PT
TNBC
Basal B
AG1024
IGF1R
RTK
7530.066
uM
inf
11.32170
0.5974 0.5039 1.3545 0.0429
0.9508
1.9710
SUM149PT
TNBC
Basal B
AG1478
EGFR
ErbB
9830.019
uM
inf
0.16990
0.3903 0.5046 1.4876 0.2572
0.9522
1.9053
SUM149PT
TNBC
Basal B
AG1478
EGFR
ErbB
7917.016
uM
8.7680
37.27210
-0.6003 -1.0000 0.7592 0.3227
0.9710
2.9532
SUM149PT
TNBC
Basal B
AS-252424
PI3K
PI3K
10819.153
uM
inf
5.99850
0.6630 0.6629 4.9979 0.0472
0.9493
2.0690
SUM149PT
TNBC
Basal B
AS-252424
PI3K
PI3K
11937.158
uM
13.12290
7.32360
0.3519 0.3447 2.0042 0.1066
0.9910
2.2386
SUM149PT
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
10819.072
uM
37.0360
125.77650
0.0119 -0.7892 0.7747 0.1821
0.9640
2.1878
SUM149PT
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7530.073
uM
87.51990
149.56760
-0.1135 -1.0000 2.0501 0.1247
0.9713
2.2072
SUM149PT
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
15330.203
uM
0.00376
0.00649
-0.8564 -0.7184 1.6353 1.2319
0.9909
1.2836
SUM149PT
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
15330.203
uM
0.00376
0.00649
-0.8564 -0.7184 1.6353 1.2319
0.9909
1.2836
SUM149PT
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7530.074
uM
0.05589
0.08823
-0.8823 -0.8633 2.1969 1.0962
0.9992
2.0964
SUM149PT
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7530.074
uM
0.05589
0.08823
-0.8823 -0.8633 2.1969 1.0962
0.9992
2.0964
SUM149PT
TNBC
Basal B
Bosutinib
Src
nRTK
10819.145
uM
1.11820
2.40540
-0.7312 -0.7053 1.1486 0.5183
0.9865
2.1971
SUM149PT
TNBC
Basal B
Bosutinib
Src
nRTK
11937.145
uM
0.84174
2.80980
-0.8457 -0.9661 0.8924 0.5737
0.9930
2.3618
SUM149PT
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
9830.011
uM
16.36670
37.26730
-0.7644 -0.8401 1.1981 0.5199
0.9951
2.0792
SUM149PT
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
7917.075
uM
24.81130
52.4970
-0.7567 -0.8108 1.2859 0.4721
0.9976
3.0479
SUM149PT
TNBC
Basal B
Cetuximab
EGFR
ErbB
9830.006
uM
inf
0.00358
0.5005 0.5059 0.9961 0.2289
0.7950
1.7160
SUM149PT
TNBC
Basal B
Cetuximab
EGFR
ErbB
7917.018
uM
inf
0.00429
0.7314 0.7201 0.5618 0.1115
0.9341
2.8573
SUM149PT
TNBC
Basal B
CGC-11047
Polyamine analogue
9830.006
uM
58.67610
450.06120
-0.9195 -1.0000 0.5392 0.4828
0.8702
1.7160